PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-253

  1. 1,399 Posts.
    lightbulb Created with Sketch. 276
    hate it that you have to cross your fingers. We have what appears to be an awesome product. We need an awesome Ceo not some part timer
    Last edited by Luckyphil1: 14/04/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.